Loading ...
passive transfusion of HLA or human neutrophil antigen ( HNA ) and corresponding antibodies from the donor directed against antigens of the recipient(passive) is caused byAntibody - mediated TRALI
T cellsinfluencedantibody class
by HLA class I(passive) caused byAntibody - mediated TRALI
an antigen binds to the extracellular portion of the chimeric antibodyto causeantibody aggregation on the surface
when an antigen binds to the extracellular portion of the chimeric antibodyto causeantibody aggregation on the surface
the factorsinfluenceantibody - mediated cytotoxicity
the pace at whichdiscoverantibody - antigen relationships
The mutationinfluencingantibody susceptibility
modificationsinfluenceantibody susceptibility
in other casesmay leadto antibody aggregation
the ability of antibodyto causeantibody - mediated
Incorrect disulfide bond formation or exchange ... side - effects of longterm mAb storagecan causeantibody aggregation
by passive transfusion of cognate antibodies and(passive) is caused byAntibody mediated
natural infection versus those produced by the Lyme Disease vaccine(passive) caused byBorrelia antibodies
by the passive infusion of antibodies from the donor reacting with the cognate antigen of the recipient(passive) is caused byAntibody mediated
to bind with their Fab regions both to a target antigen and to a conjugate or effector cell(passive) can also be designedBispecific antibodies
to bind simultaneously to two different epitopes , such as a tumor antigen and a receptor on an immune effector cell with the objective to redirect effector cells to cancer cell killing(passive) are designedBispecific antibodies
Increasing R&D pertaining to the use of monoclonal bodies as naked antigen binding antibodies , conjugated , andis resultingbispecific antibodies
membrane filtrationcausesIgG aggregation
the composition of the culture media(passive) is significantly influenced byAntibody glycosylation
by Memorial Sloan - Kettering(passive) were discoveredbispecific antibodies
chemiluminscence ( 4(passive) was discovered byAntibody presenting
by creating multiple hybrid sequences that fuse select parts of the parental antibody sequence with the human framework sequences(passive) were designedHumanized antibodies
as follows(passive) can be designedHumanized antibodies
by Memorial Sloan - Kettering for the treatment of neuroblastoma in children(passive) were discovered bybispecific antibodies
Memorial Sloan - Kettering for the treatment of neuroblastoma in children(passive) were discovered bybispecific antibodies
by Memorial Sloan - Kettering for the treatment of neuroblastoma in children(passive) were discoveredbispecific antibodies
most frequently(passive) had been ... discoveredTIMP-2 antibodies
chemiluminscence using the Supersignal chemiluminscent substrate ( ThermoScientific , Rockford , IL ) as referred to ( 4(passive) was discovered byAntibody presenting
because of the conjugation processwo ... be ... influencedbecause of the conjugation process
through the conjugation procedurewo ... be ... influencedthrough the conjugation procedure
in off - target binding yielding false positive resultscan resultin off - target binding yielding false positive results
to chemotaxis and producing homotypic PMNleadto chemotaxis and producing homotypic PMN
this problem(passive) can ... be caused bythis problem
to activation of the classical complement cascadeleadto activation of the classical complement cascade
in more tumor shrinkagecould resultin more tumor shrinkage
to better relapse - free survivalledto better relapse - free survival
to the development of acute cellular rejectionleadingto the development of acute cellular rejection
antigen(passive) are designedantigen
only agglutination of erythrocytescauseonly agglutination of erythrocytes
of fragments of twocomposedof fragments of two
of two antibodies or antibody fragments having different binding specificities linked togetherare composedof two antibodies or antibody fragments having different binding specificities linked together
to engage cytotoxic T cells and trigger tumor cell killingdesignedto engage cytotoxic T cells and trigger tumor cell killing
to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid FeaturesLeadsto a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features
false - positive resultscould causefalse - positive results
to assess protein profiling ( global regulation and post - translational modifications ) in cells , biopsies and biological fluidsdesignedto assess protein profiling ( global regulation and post - translational modifications ) in cells , biopsies and biological fluids
with the high - affinity C8.2.5 scFv as well as the wild - type 2D12.5designedwith the high - affinity C8.2.5 scFv as well as the wild - type 2D12.5
charge heterogeneitycould causecharge heterogeneity
to tumor rejectionalbeit in combination with anti CTLA-4 antibody ledto tumor rejection
the thyroglobulin level to be artificially suppressedwill causethe thyroglobulin level to be artificially suppressed
a persistent infection in horsescausesa persistent infection in horses
in improved tumor - non - tumor ratiosresultedin improved tumor - non - tumor ratios
from the 2-doseresultingfrom the 2-dose
to Russell body formationleadingto Russell body formation